TreeWAS – Variant ID: rs2303670

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L60.0 Ingrowing nail	0.052	0.948	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.033	0.967	0.000
L80-L99 Other disorders of the skin and subcutaneous tissue	0.032	0.968	0.000
L81 Other disorders of pigmentation	0.032	0.968	0.000
Z57.2 Occupational exposure to dust	0.032	0.968	0.000
L84 Corns and callosities	0.031	0.969	0.000
Z57 Occupational exposure to risk-factors	0.030	0.970	0.000
L60 Nail disorders	0.030	0.970	0.000
L89 Decubitus ulcer	0.030	0.970	0.000
L81.4 Other melanin hyperpigmentation	0.030	0.970	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.029	0.971	0.000
L81.9 Disorder of pigmentation, unspecified	0.028	0.972	0.000
L93 Lupus erythematosus	0.028	0.972	0.000
L89.1 Stage II decubitus ulcer	0.027	0.973	0.000
Z57.3 Occupational exposure to other air contaminants	0.027	0.973	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.026	0.974	0.000
L93.0 Discoid lupus erythematosus	0.024	0.975	0.000
L81.2 Freckles	0.024	0.976	0.000
L94 Other localised connective tissue disorders	0.024	0.976	0.000
L83 Acanthosis nigricans	0.024	0.976	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.024	0.976	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.023	0.976	0.000
L81.8 Other specified disorders of pigmentation	0.023	0.976	0.000
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.023	0.977	0.000
L87 Transepidermal elimination disorders	0.023	0.977	0.000
L88 Pyoderma gangrenosum	0.023	0.977	0.000
L86 Keratoderma in diseases classified elsewhere	0.023	0.977	0.000
L81.7 Pigmented purpuric dermatosis	0.023	0.977	0.000
L81.6 Other disorders of diminished melanin formation	0.023	0.977	0.000
L81.5 Leukoderma, not elsewhere classified	0.023	0.977	0.000
L81.3 Cafe au lait spots	0.023	0.977	0.000
L81.1 Chloasma	0.023	0.977	0.000
L81.0 Postinflammatory hyperpigmentation	0.023	0.977	0.000
L60.9 Nail disorder, unspecified	0.023	0.977	0.000
L91 Hypertrophic disorders of skin	0.022	0.978	0.000
Z57.9 Occupational exposure to unspecified risk-factor	0.022	0.978	0.000
Z57.8 Occupational exposure to other risk-factors	0.022	0.978	0.000
Z57.7 Occupational exposure to vibration	0.022	0.978	0.000
Z57.6 Occupational exposure to extreme temperature	0.022	0.978	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.022	0.978	0.000
Z57.1 Occupational exposure to radiation	0.022	0.978	0.000
Z57.0 Occupational exposure to noise	0.022	0.978	0.000
L60.5 Yellow nail syndrome	0.021	0.978	0.000
L60.4 Beau's lines	0.021	0.978	0.000
L60.1 Onycholysis	0.021	0.978	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.021	0.979	0.000
L90 Atrophic disorders of skin	0.021	0.979	0.000
L89.3 Stage IV decubitus ulcer	0.021	0.979	0.000
L60.3 Nail dystrophy	0.021	0.979	0.000
L93.2 Other local lupus erythematosus	0.020	0.980	0.000
L93.1 Subacute cutaneous lupus erythematosus	0.020	0.980	0.000
L60-L75 Disorders of skin appendages	0.020	0.980	0.000
L60.8 Other nail disorders	0.019	0.981	0.000
L89.2 Stage III decubitus ulcer	0.019	0.981	0.000
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.018	0.981	0.000
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.018	0.981	0.000
L60.2 Onychogryphosis	0.018	0.981	0.000
L92.0 Granuloma annulare	0.018	0.981	0.000
L95 Vasculitis limited to skin, not elsewhere classified	0.018	0.982	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.018	0.982	0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.018	0.982	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.018	0.982	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.018	0.982	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.018	0.982	0.000
C43.5 Malignant melanoma of trunk	0.018	0.982	0.000
L94.2 Calcinosis cutis	0.018	0.982	0.000
L91.8 Other hypertrophic disorders of skin	0.018	0.982	0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.018	0.982	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.018	0.982	0.000
L94.0 Localised scleroderma [morphea]	0.017	0.983	0.000
L94.9 Localised connective tissue disorder, unspecified	0.017	0.983	0.000
L94.8 Other specified localised connective tissue disorders	0.017	0.983	0.000
L94.6 Ainhum	0.017	0.983	0.000
L94.5 Poikiloderma vasculare atrophicans	0.017	0.983	0.000
L94.4 Gottron's papules	0.017	0.983	0.000
L94.3 Sclerodactyly	0.017	0.983	0.000
L94.1 Linear scleroderma	0.017	0.983	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.017	0.983	0.000
L98.0 Pyogenic granuloma	0.017	0.983	0.000
L87.9 Transepidermal elimination disorder, unspecified	0.017	0.983	0.000
L87.8 Other transepidermal elimination disorders	0.017	0.983	0.000
L87.2 Elastosis perforans serpiginosa	0.017	0.983	0.000
L87.1 Reactive perforating collagenosis	0.017	0.983	0.000
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]	0.017	0.983	0.000
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.017	0.983	0.000
L99.0 Amyloidosis of skin	0.017	0.983	0.000
L80 Vitiligo	0.016	0.983	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.017	0.983	0.000
L90.5 Scar conditions and fibrosis of skin	0.017	0.983	0.000
L70 Acne	0.016	0.984	0.000
N32.3 Diverticulum of bladder	0.000	0.984	0.016
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.016	0.984	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.016	0.984	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.016	0.984	0.000
L85 Other epidermal thickening	0.016	0.984	0.000
L90.9 Atrophic disorder of skin, unspecified	0.015	0.984	0.000
L90.8 Other atrophic disorders of skin	0.015	0.984	0.000
L90.6 Striae atrophicae	0.015	0.984	0.000
L90.4 Acrodermatitis chronica atrophicans	0.015	0.984	0.000
L90.3 Atrophoderma of Pasini and Pierini	0.015	0.984	0.000
L90.2 Anetoderma of Jadassohn-Pellizzari	0.015	0.984	0.000
L90.1 Anetoderma of Schweninger-Buzzi	0.015	0.984	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.015	0.984	0.000
T43.2 Other and unspecified antidepressants	0.015	0.985	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.015	0.985	0.000
L68 Hypertrichosis	0.015	0.985	0.000
L71 Rosacea	0.015	0.985	0.000
L75 Apocrine sweat disorders	0.014	0.985	0.000
L74 Eccrine sweat disorders	0.014	0.985	0.000
L67 Hair colour and hair shaft abnormalities	0.014	0.985	0.000
L66 Cicatricial alopecia [scarring hair loss]	0.014	0.985	0.000
L64 Androgenic alopecia	0.014	0.985	0.000
L63 Alopecia areata	0.014	0.985	0.000
L62 Nail disorders in diseases classified elsewhere	0.014	0.985	0.000
L40-L45 Papulosquamous disorders	0.014	0.986	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.014	0.986	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.014	0.986	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.014	0.986	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.014	0.986	0.000
L40.0 Psoriasis vulgaris	0.014	0.986	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.014	0.986	0.000
L40 Psoriasis	0.014	0.986	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.014	0.986	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.014	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.014	0.986	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.014	0.986	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.014	0.986	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.014	0.986	0.000
L70.0 Acne vulgaris	0.014	0.986	0.000
L95.1 Erythema elevatum diutinum	0.013	0.986	0.000
L95.0 Livedoid vasculitis	0.013	0.986	0.000
T45.2 Vitamins, not elsewhere classified	0.013	0.987	0.000
T46.1 Calcium-channel blockers	0.013	0.987	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.013	0.987	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.013	0.987	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.013	0.987	0.000
L73 Other follicular disorders	0.013	0.987	0.000
L10-L14 Bullous disorders	0.013	0.987	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.013	0.987	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.013	0.987	0.000
T46.7 Peripheral vasodilators	0.013	0.987	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.013	0.987	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.013	0.987	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.013	0.987	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.013	0.987	0.000
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.013	0.987	0.000
L98.3 Eosinophilic cellulitis [Wells]	0.013	0.987	0.000
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.013	0.987	0.000
L98.1 Factitial dermatitis	0.013	0.987	0.000
T43.9 Psychotropic drug, unspecified	0.013	0.987	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T43.6 Psychostimulants with abuse potential	0.013	0.987	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.013	0.987	0.000
L98.5 Mucinosis of skin	0.013	0.987	0.000
L91.0 Keloid scar	0.013	0.987	0.000
T36 Poisoning by systemic antibiotics	0.013	0.987	0.000
T50.4 Drugs affecting uric acid metabolism	0.013	0.987	0.000
L50-L54 Urticaria and erythema	0.013	0.987	0.000
L71.8 Other rosacea	0.012	0.987	0.000
T45.5 Anticoagulants	0.012	0.987	0.000
L65 Other nonscarring hair loss	0.012	0.988	0.000
T45.0 Antiallergic and antiemetic drugs	0.012	0.988	0.000
L98.4 Chronic ulcer of skin, not elsewhere classified	0.012	0.988	0.000
L95.8 Other vasculitis limited to skin	0.012	0.988	0.000
L71.1 Rhinophyma	0.012	0.988	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.012	0.988	0.000
T50.8 Diagnostic agents	0.012	0.988	0.000
T50.7 Analeptics and opioid receptor antagonists	0.012	0.988	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.012	0.988	0.000
T50.5 Appetite depressants	0.012	0.988	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.012	0.988	0.000
T50.1 Loop [high-ceiling] diuretics	0.012	0.988	0.000
T50.0 Mineralocorticoids and their antagonists	0.012	0.988	0.000
L90.0 Lichen sclerosus et atrophicus	0.012	0.988	0.000
L70.8 Other acne	0.012	0.988	0.000
L70.5 Acne excoriee des jeunes filles	0.012	0.988	0.000
L70.4 Infantile acne	0.012	0.988	0.000
L70.3 Acne tropica	0.012	0.988	0.000
L70.2 Acne varioliformis	0.012	0.988	0.000
L70.1 Acne conglobata	0.012	0.988	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.012	0.988	0.000
L70.9 Acne, unspecified	0.012	0.988	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.012	0.988	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.988	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.988	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.988	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.988	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.988	0.000
T44.0 Anticholinesterase agents	0.011	0.988	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.011	0.988	0.000
T45.8 Other primarily systemic and haematological agents	0.011	0.988	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.011	0.988	0.000
T45.6 Fibrinolysis-affecting drugs	0.011	0.988	0.000
T45.4 Iron and its compounds	0.011	0.988	0.000
T45.3 Enzymes, not elsewhere classified	0.011	0.988	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.011	0.988	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.011	0.988	0.000
T47.7 Emetics	0.011	0.988	0.000
T47.6 Antidiarrhoeal drugs	0.011	0.988	0.000
T47.5 Digestants	0.011	0.988	0.000
T47.4 Other laxatives	0.011	0.988	0.000
T47.3 Saline and osmotic laxatives	0.011	0.988	0.000
T47.2 Stimulant laxatives	0.011	0.988	0.000
T47.0 Histamine H(2)-receptor antagonists	0.011	0.988	0.000
L20-L30 Dermatitis and eczema	0.012	0.988	0.000
L85.3 Xerosis cutis	0.011	0.988	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.011	0.988	0.000
L85.0 Acquired ichthyosis	0.011	0.988	0.000
L68.0 Hirsutism	0.011	0.989	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.011	0.989	0.000
L68.9 Hypertrichosis, unspecified	0.011	0.989	0.000
L68.8 Other hypertrichosis	0.011	0.989	0.000
L68.3 Polytrichia	0.011	0.989	0.000
L68.2 Localised hypertrichosis	0.011	0.989	0.000
L68.1 Acquired hypertrichosis lanuginosa	0.011	0.989	0.000
L71.0 Perioral dermatitis	0.011	0.989	0.000
L30 Other dermatitis	0.011	0.989	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.011	0.989	0.000
L40.5 Arthropathic psoriasis	0.011	0.989	0.000
L62.8 Nail disorders in other diseases classified elsewhere	0.010	0.989	0.000
L62.0 Clubbed nail pachydermoperiostosis	0.010	0.989	0.000
L63.9 Alopecia areata, unspecified	0.010	0.989	0.000
L63.8 Other alopecia areata	0.010	0.989	0.000
L63.2 Ophiasis	0.010	0.989	0.000
L63.1 Alopecia universalis	0.010	0.989	0.000
L63.0 Alopecia (capitis) totalis	0.010	0.989	0.000
L64.9 Androgenic alopecia, unspecified	0.010	0.989	0.000
L64.8 Other androgenic alopecia	0.010	0.989	0.000
L64.0 Drug-induced androgenic alopecia	0.010	0.989	0.000
L66.9 Cicatricial alopecia, unspecified	0.010	0.989	0.000
L66.8 Other cicatricial alopecia	0.010	0.989	0.000
L66.4 Folliculitis ulerythematosa reticulata	0.010	0.989	0.000
L66.3 Perifolliculitis capitis abscedens	0.010	0.989	0.000
L66.2 Folliculitis decalvans	0.010	0.989	0.000
L66.1 Lichen planopilaris	0.010	0.989	0.000
L66.0 Pseudopelade	0.010	0.989	0.000
L67.9 Hair colour and hair shaft abnormality, unspecified	0.010	0.989	0.000
L67.8 Other hair colour and hair shaft abnormalities	0.010	0.989	0.000
L67.1 Variations in hair colour	0.010	0.989	0.000
L67.0 Trichorrhexis nodosa	0.010	0.989	0.000
L74.9 Eccrine sweat disorder, unspecified	0.010	0.989	0.000
L74.8 Other eccrine sweat disorders	0.010	0.989	0.000
L74.4 Anhidrosis	0.010	0.989	0.000
L74.3 Miliaria, unspecified	0.010	0.989	0.000
L74.2 Miliaria profunda	0.010	0.989	0.000
L74.1 Miliaria crystallina	0.010	0.989	0.000
L74.0 Miliaria rubra	0.010	0.989	0.000
L75.9 Apocrine sweat disorder, unspecified	0.010	0.989	0.000
L75.8 Other apocrine sweat disorders	0.010	0.989	0.000
L75.2 Apocrine miliaria	0.010	0.989	0.000
L75.1 Chromhidrosis	0.010	0.989	0.000
L75.0 Bromhidrosis	0.010	0.989	0.000
L73.8 Other specified follicular disorders	0.011	0.989	0.000
L44 Other papulosquamous disorders	0.010	0.989	0.000
L41 Parapsoriasis	0.010	0.989	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.010	0.989	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.010	0.989	0.000
T37.5 Antiviral drugs	0.010	0.989	0.000
T37.4 Anthelminthics	0.010	0.989	0.000
T37.3 Other antiprotozoal drugs	0.010	0.989	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.010	0.989	0.000
T37.1 Antimycobacterial drugs	0.010	0.989	0.000
T37.0 Sulphonamides	0.010	0.989	0.000
T38.1 Thyroid hormones and substitutes	0.010	0.989	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.011	0.989	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.011	0.989	0.000
L95.9 Vasculitis limited to skin, unspecified	0.010	0.989	0.000
T38.9 Other and unspecified hormone antagonists	0.010	0.990	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
T38.7 Androgens and anabolic congeners	0.010	0.990	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.010	0.990	0.000
T38.5 Other oestrogens and progestogens	0.010	0.990	0.000
T38.4 Oral contraceptives	0.010	0.990	0.000
T38.2 Antithyroid drugs	0.010	0.990	0.000
T38.0 Glucocorticoids and synthetic analogues	0.010	0.990	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.010	0.990	0.000
L40.9 Psoriasis, unspecified	0.010	0.990	0.000
L40.4 Guttate psoriasis	0.010	0.990	0.000
L40.3 Pustulosis palmaris et plantaris	0.010	0.990	0.000
L40.2 Acrodermatitis continua	0.010	0.990	0.000
L40.1 Generalised pustular psoriasis	0.010	0.990	0.000
M89 Other disorders of bone	0.010	0.990	0.000
L51 Erythema multiforme	0.010	0.990	0.000
L53 Other erythematous conditions	0.010	0.990	0.000
T41.5 Therapeutic gases	0.010	0.990	0.000
T41.4 Anaesthetic, unspecified	0.010	0.990	0.000
T41.3 Local anaesthetics	0.010	0.990	0.000
T41.2 Other and unspecified general anaesthetics	0.010	0.990	0.000
T41.1 Intravenous anaesthetics	0.010	0.990	0.000
T41.0 Inhaled anaesthetics	0.010	0.990	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.010	0.990	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.010	0.990	0.000
T48.5 Anti-common-cold drugs	0.010	0.990	0.000
T48.4 Expectorants	0.010	0.990	0.000
T48.3 Antitussives	0.010	0.990	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.010	0.990	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.010	0.990	0.000
T48.0 Oxytocic drugs	0.010	0.990	0.000
T49.9 Topical agent, unspecified	0.010	0.990	0.000
T49.8 Other topical agents	0.010	0.990	0.000
T49.7 Dental drugs, topically applied	0.010	0.990	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.010	0.990	0.000
T49.5 Ophthalmological drugs and preparations	0.010	0.990	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.010	0.990	0.000
T49.3 Emollients, demulcents and protectants	0.010	0.990	0.000
T49.2 Local astringents and local detergents	0.010	0.990	0.000
T49.1 Antipruritics	0.010	0.990	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.010	0.990	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.010	0.990	0.000
L11 Other acantholytic disorders	0.010	0.990	0.000
Z63 Other problems related to primary support group, including family circumstances	0.010	0.990	0.000
L73.1 Pseudofolliculitis barbae	0.010	0.990	0.000
L73.0 Acne keloid	0.010	0.990	0.000
L13 Other bullous disorders	0.010	0.990	0.000
L10 Pemphigus	0.010	0.990	0.000
L14 Bullous disorders in diseases classified elsewhere	0.010	0.990	0.000
L12 Pemphigoid	0.009	0.990	0.000
M89.8 Other specified disorders of bone	0.010	0.990	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.009	0.990	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.009	0.990	0.000
T42.3 Barbiturates	0.009	0.990	0.000
T42.2 Succinimides and oxazolidinediones	0.009	0.990	0.000
T42.0 Hydantoin derivatives	0.009	0.990	0.000
Z64 Problems related to certain psychosocial circumstances	0.009	0.990	0.000
L40.8 Other psoriasis	0.009	0.990	0.000
M89.0 Algoneurodystrophy	0.009	0.991	0.000
T36.9 Systemic antibiotic, unspecified	0.009	0.991	0.000
T36.8 Other systemic antibiotics	0.009	0.991	0.000
T36.7 Antifungal antibiotics, systemically used	0.009	0.991	0.000
T36.6 Rifamycins	0.009	0.991	0.000
T36.5 Aminoglycosides	0.009	0.991	0.000
T36.4 Tetracyclines	0.009	0.991	0.000
T36.3 Macrolides	0.009	0.991	0.000
T36.2 Chloramphenicol group	0.009	0.991	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.009	0.991	0.000
L42 Pityriasis rosea	0.009	0.991	0.000
L30.8 Other specified dermatitis	0.009	0.991	0.000
L54 Erythema in diseases classified elsewhere	0.009	0.991	0.000
L30.3 Infective dermatitis	0.009	0.991	0.000
T39.0 Salicylates	0.009	0.991	0.000
L65.8 Other specified nonscarring hair loss	0.009	0.991	0.000
L65.2 Alopecia mucinosa	0.009	0.991	0.000
L65.1 Anagen effluvium	0.009	0.991	0.000
L65.0 Telogen effluvium	0.009	0.991	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.009	0.991	0.000
M89.3 Hypertrophy of bone	0.009	0.991	0.000
Z59 Problems related to housing and economic circumstances	0.009	0.991	0.000
G93.6 Cerebral oedema	0.009	0.991	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.009	0.991	0.000
T36.0 Penicillins	0.009	0.991	0.000
Z63.4 Disappearance and death of family member	0.009	0.991	0.000
L23 Allergic contact dermatitis	0.009	0.991	0.000
L73.2 Hidradenitis suppurativa	0.009	0.991	0.000
L53.9 Erythematous condition, unspecified	0.009	0.991	0.000
L25 Unspecified contact dermatitis	0.009	0.991	0.000
Z65 Problems related to other psychosocial circumstances	0.009	0.991	0.000
Z62 Other problems related to upbringing	0.009	0.991	0.000
Z61 Problems related to negative life events in childhood	0.009	0.991	0.000
Z55 Problems related to education and literacy	0.009	0.991	0.000
M86-M90 Other osteopathies	0.009	0.991	0.000
M86 Osteomyelitis	0.009	0.991	0.000
L20 Atopic dermatitis	0.008	0.991	0.000
T42.1 Iminostilbenes	0.008	0.991	0.000
L24 Irritant contact dermatitis	0.008	0.991	0.000
L26 Exfoliative dermatitis	0.008	0.991	0.000
L22 Diaper [napkin] dermatitis	0.008	0.991	0.000
M86.9 Osteomyelitis, unspecified	0.008	0.992	0.000
G62.9 Polyneuropathy, unspecified	0.008	0.992	0.000
L28 Lichen simplex chronicus and prurigo	0.008	0.992	0.000
M89.84 Other specified disorders of bone (Hand)	0.008	0.992	0.000
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.008	0.992	0.000
L50 Urticaria	0.008	0.992	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.008	0.992	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.008	0.992	0.000
M90 Osteopathies in diseases classified elsewhere	0.008	0.992	0.000
M89.88 Other specified disorders of bone (Other)	0.008	0.992	0.000
L30.9 Dermatitis, unspecified	0.008	0.992	0.000
L52 Erythema nodosum	0.008	0.992	0.000
L51.9 Erythema multiforme, unspecified	0.008	0.992	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.008	0.992	0.000
L30.5 Pityriasis alba	0.008	0.992	0.000
L30.4 Erythema intertrigo	0.008	0.992	0.000
L30.2 Cutaneous autosensitisation	0.008	0.992	0.000
L30.1 Dyshidrosis [pompholyx]	0.008	0.992	0.000
L30.0 Nummular dermatitis	0.008	0.992	0.000
G62 Other polyneuropathies	0.008	0.992	0.000
M89.38 Hypertrophy of bone (Other)	0.008	0.992	0.000
M90.7 Fracture of bone in neoplastic disease	0.008	0.992	0.000
L41.9 Parapsoriasis, unspecified	0.008	0.992	0.000
L41.8 Other parapsoriasis	0.008	0.992	0.000
L41.5 Retiform parapsoriasis	0.008	0.992	0.000
L41.4 Large plaque parapsoriasis	0.008	0.992	0.000
L41.3 Small plaque parapsoriasis	0.008	0.992	0.000
L41.2 Lymphomatoid papulosis	0.008	0.992	0.000
L41.1 Pityriasis lichenoides chronica	0.008	0.992	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.008	0.992	0.000
L44.9 Papulosquamous disorder, unspecified	0.008	0.992	0.000
L44.8 Other specified papulosquamous disorders	0.008	0.992	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.008	0.992	0.000
L44.3 Lichen ruber moniliformis	0.008	0.992	0.000
L44.2 Lichen striatus	0.008	0.992	0.000
L44.1 Lichen nitidus	0.008	0.992	0.000
L44.0 Pityriasis rubra pilaris	0.008	0.992	0.000
L73.9 Follicular disorder, unspecified	0.008	0.992	0.000
T40.2 Other opioids	0.008	0.992	0.000
Z64.0 Problems related to unwanted pregnancy	0.008	0.992	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.008	0.992	0.000
T40.8 Lysergide [LSD]	0.008	0.992	0.000
T40.7 Cannabis (derivatives)	0.008	0.992	0.000
T40.5 Cocaine	0.008	0.992	0.000
T40.3 Methadone	0.008	0.992	0.000
T40.1 Heroin	0.008	0.992	0.000
T40.0 Opium	0.008	0.992	0.000
L21 Seborrhoeic dermatitis	0.008	0.992	0.000
T39.4 Antirheumatics, not elsewhere classified	0.008	0.992	0.000
T39.2 Pyrazolone derivatives	0.008	0.992	0.000
M89.04 Algoneurodystrophy (Hand)	0.008	0.992	0.000
G60 Hereditary and idiopathic neuropathy	0.008	0.992	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.008	0.992	0.000
G93.0 Cerebral cysts	0.008	0.992	0.000
Z56 Problems related to employment and unemployment	0.008	0.992	0.000
Z58 Problems related to physical environment	0.007	0.992	0.000
L51.1 Bullous erythema multiforme	0.007	0.992	0.000
M89.03 Algoneurodystrophy (Forearm)	0.007	0.992	0.000
M89.6 Osteopathy after poliomyelitis	0.007	0.992	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.007	0.992	0.000
M89.2 Other disorders of bone development and growth	0.007	0.992	0.000
M89.1 Epiphyseal arrest	0.007	0.992	0.000
G63.2 Diabetic polyneuropathy	0.008	0.992	0.000
M89.9 Disorder of bone, unspecified	0.007	0.992	0.000
L51.8 Other erythema multiforme	0.007	0.993	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.007	0.993	0.000
L51.0 Nonbullous erythema multiforme	0.007	0.993	0.000
L53.3 Other chronic figurate erythema	0.007	0.993	0.000
L53.2 Erythema marginatum	0.007	0.993	0.000
L53.1 Erythema annulare centrifugum	0.007	0.993	0.000
L53.0 Toxic erythema	0.007	0.993	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.007	0.993	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.007	0.993	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.007	0.993	0.000
T40.4 Other synthetic narcotics	0.007	0.993	0.000
Z63.8 Other specified problems related to primary support group	0.007	0.993	0.000
G93 Other disorders of brain	0.007	0.993	0.000
L11.0 Acquired keratosis follicularis	0.007	0.993	0.000
Z63.7 Other stressful life events affecting family and household	0.007	0.993	0.000
Z59.1 Inadequate housing	0.007	0.993	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.007	0.993	0.000
L11.9 Acantholytic disorder, unspecified	0.007	0.993	0.000
L11.8 Other specified acantholytic disorders	0.007	0.993	0.000
L11.1 Transient acantholytic dermatosis [Grover]	0.007	0.993	0.000
Z63.9 Problem related to primary support group, unspecified	0.007	0.993	0.000
Z63.6 Dependent relative needing care at home	0.007	0.993	0.000
Z63.3 Absence of family member	0.007	0.993	0.000
Z63.2 Inadequate family support	0.007	0.993	0.000
Z63.1 Problems in relationship with parents and in-laws	0.007	0.993	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.007	0.993	0.000
L10.9 Pemphigus, unspecified	0.007	0.993	0.000
L10.8 Other pemphigus	0.007	0.993	0.000
L10.5 Drug-induced pemphigus	0.007	0.993	0.000
L10.4 Pemphigus erythematosus	0.007	0.993	0.000
L10.3 Brazilian pemphigus [fogo selvagem]	0.007	0.993	0.000
L10.2 Pemphigus foliaceus	0.007	0.993	0.000
L10.1 Pemphigus vegetans	0.007	0.993	0.000
L10.0 Pemphigus vulgaris	0.007	0.993	0.000
L13.9 Bullous disorder, unspecified	0.007	0.993	0.000
L13.8 Other specified bullous disorders	0.007	0.993	0.000
L13.1 Subcorneal pustular dermatitis	0.007	0.993	0.000
L13.0 Dermatitis herpetiformis	0.007	0.993	0.000
G60.0 Hereditary motor and sensory neuropathy	0.007	0.993	0.000
L12.9 Pemphigoid, unspecified	0.007	0.993	0.000
L12.8 Other pemphigoid	0.007	0.993	0.000
L12.3 Acquired epidermolysis bullosa	0.007	0.993	0.000
L12.2 Chronic bullous disease of childhood	0.007	0.993	0.000
L12.1 Cicatricial pemphigoid	0.007	0.993	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.007	0.993	0.000
M89.83 Other specified disorders of bone (Forearm)	0.007	0.993	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.007	0.993	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.007	0.993	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.007	0.993	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.007	0.993	0.000
Z59.0 Homelessness	0.007	0.993	0.000
Z60 Problems related to social environment	0.007	0.993	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.007	0.993	0.000
L12.0 Bullous pemphigoid	0.007	0.993	0.000
L65.9 Nonscarring hair loss, unspecified	0.007	0.993	0.000
Z64.4 Discord with counsellors	0.007	0.993	0.000
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful	0.007	0.993	0.000
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful	0.007	0.993	0.000
Z64.1 Problems related to multiparity	0.007	0.993	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.007	0.993	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.007	0.993	0.000
M89.08 Algoneurodystrophy (Other)	0.007	0.993	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.007	0.993	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.007	0.993	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.007	0.993	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.007	0.993	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations